Cumberland Pharma (CPIX) Reports Solid Q2 Results
Tweet
Share
E-mail
Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q2 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $12.21 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M
- Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
- MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
